Composition
Each film coated tablet contains:
| Levocetirizine Hydrochloride IP |
5 mg. |
| Montelukast Sodium IP eq. to Montelukast |
10 mg. |
| Excipients |
Q.S. |
- Displays dual modes of action to counter allergic manifestations
- Montelukast: Inhibits leukotrienes & produces anti-inflammatory and brochodilating effects
- Levocetirizine: Inhibits histamine action at H1 receptors and reduces allergic manifestations
- Considered as a more effective strategy in allergic rhinitis Combination therapy (Montelukast + Levocetirizine) is a more effective strategy than monotherapy in the treatment of persistent allergic rhinitis."
- Improves quality of life of affected patient
Indication
- Seasonal Allergic Rhinitis
- COPD
- Perennial Allergic Rhinitis
- Chronic Urticaria
- Bronchial Asthma
- Contact Dermatitis
